123 related articles for article (PubMed ID: 16403488)
21. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium.
Donders GG; Gabrovska M; Bellen G; Van Keirsbilck J; Van Den Bosch T; Riphagen I; Verjans M
Arch Gynecol Obstet; 2008 Apr; 277(4):291-8. PubMed ID: 17965870
[TBL] [Abstract][Full Text] [Related]
22. Linking cervical cancer to the human papillomavirus: findings from a qualitative study with Mexican women.
Garcia SG; Becker D; Tatum C; Aldrich T; Fernández-C A
Health Care Women Int; 2007 Feb; 28(2):192-205. PubMed ID: 17364980
[TBL] [Abstract][Full Text] [Related]
23. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].
Sopracordevole F; Cigolot F; Lucia E; Marchesoni D
Minerva Ginecol; 2009 Apr; 61(2):81-7. PubMed ID: 19255555
[TBL] [Abstract][Full Text] [Related]
24. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
25. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
27. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
Franco EL; Cuzick J; Hildesheim A; de Sanjosé S
Vaccine; 2006 Aug; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
[TBL] [Abstract][Full Text] [Related]
28. Initial lessons learned in HPV vaccination.
Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
[TBL] [Abstract][Full Text] [Related]
29. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
Zaratti L; Senatore S; Franco E
Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
[TBL] [Abstract][Full Text] [Related]
30. Awareness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece.
Dinas K; Nasioutziki M; Arvanitidou O; Mavromatidis G; Loufopoulos P; Pantazis K; Dovas D; Daniilidis A; Tsampazis N; Zepiridis L; Theodoridis T; Loufopoulos A
J Obstet Gynaecol; 2009 Aug; 29(6):542-6. PubMed ID: 19697207
[TBL] [Abstract][Full Text] [Related]
31. Chapter 10: New dimensions in cervical cancer screening.
Cuzick J; Mayrand MH; Ronco G; Snijders P; Wardle J
Vaccine; 2006 Aug; 24 Suppl 3():S3/90-7. PubMed ID: 16950022
[TBL] [Abstract][Full Text] [Related]
32. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening today. The role of HPV DNA testing.
Berman NR
Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
[No Abstract] [Full Text] [Related]
34. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
35. What do women in the U.S. know about human papillomavirus and cervical cancer?
Tiro JA; Meissner HI; Kobrin S; Chollette V
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):288-94. PubMed ID: 17267388
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of cervical cancer.
Sasieni P
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):295-305. PubMed ID: 16386963
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
38. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
39. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine.
Dursun P; Altuntas B; Kuscu E; Ayhan A
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):202-6. PubMed ID: 19432612
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
